Neurodegenerative diseases;Neurodegenerative erkrankungen (ZNS) - Eine aktuelle übersicht

Journal fur Neurologie, Neurochirurgie und Psychiatrie

Volumn 6, Issue 1, 2005, Pages 9-18

  Jellinger, Kurt A ^a  

^a Inst fur Klinische Neurobiologie   (Austria)

Author keywords

Alzheimer disease; Clinic; Diagnosis; Epidemiology; Neurodegenerative diseases; Parkinson disease; Pathogenesis

Indexed keywords

AGE DISTRIBUTION; ALZHEIMER DISEASE; BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM; CLASSIFICATION; DEGENERATIVE DISEASE; DISEASE COURSE; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; GENETIC DISORDER; GLIA; HUMAN; METABOLIC DISORDER; MOLECULAR BIOLOGY; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; NERVE CELL; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; POLYAMINE METABOLISM; POPULATION RISK; PREVALENCE; PRION DISEASE; PROTEIN DEGRADATION; PROTEIN FOLDING; RARE DISEASE; REACTION OPTIMIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 17144379629     PISSN: 16081587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM. Protein misfolding in neurodegenerative diseases. Neuropathol Appl Neurobiol 2004; 30: 215-24.
2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
3. Cairns NJ, Lee VM, Trojanowski JQ. The cytoskeleton in neurodegenerative diseases. J Pathol 2004; 204: 438-49.
4. Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM, Trojanowski JQ. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004; 63: 1376-84.
5. Crompton DE, Chinnery PF, Bates D, Walls TJ, Jackson MJ, Curtis AJ, Burn J. Spectrum of movement disorders in neuroferritinopathy. Mov Disord 2004.
6. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001; 28: 350-4.
7. Dickson D (ed.) Neurodegeneration: The molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, 2003.
8. Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10: 1055-63.
9. th ed., Lippincott Williams & Wilkins, Philadelphia; 2002.
10. Jellinger KA. Neuropathology of Alzheimer disease. Myths, facts, and conclusions. Klinik 2003; 13: 9-13.
11. Jellinger KA. Neurodegenerative Erkrankungen - eine Anti-Aging- Herausforderung. In: Jakobi G (ed). Kursbuch Anti-Aging. G. Thieme, Stuttgart, New York, 2004; 127-32.
12. Jellinger KA. Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 2004; 111: 1219-35.
13. Jellinger KA. General aspects of neurodegeneration. J Neurol Transm 2003; (Suppl 65): 101-44.
14. Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003; 126: 2291-303.
15. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004; 10 (Suppl): S10-7.
16. Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004; 6: 1054-61.
17. Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, Siani V, Benson MD, Calvas P, Miravalle L, Rascol O, Delisle MB. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 2004; 63: 363-80.
18. Wirths O, Multhaup G, Bayer TA. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide - the first step of a fatal cascade. J Neurochem 2004; 91: 513-20.